Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Recently, a GLS1 selective inhibitor, CB-839 (telaglenastat), tested in preclinical trials showed no significant side effects and, therefore, was moved forward into clinical trials
Human breast milk composition and function in human health: from nutritional components to microbiome and microRNAs
By understanding how your body works, you can take simple, proactive steps to support your health, naturally
For a 52-year-old executive experiencing cognitive decline that's affecting job performance, spending $1,000-$2,400 on an initial NAD+ protocol to see if it restores clarity might be a rational investment
US$ 27.51
US$ 28.46
US$ 27.90
US$ 29.32
